Affinity DataKd: 1nMAssay Description:Binding constant for DRAK1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 1nMAssay Description:Binding affinity to DRAK1More data for this Ligand-Target Pair
Affinity DataKd: 1nMAssay Description:Binding constant for DRAK1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 1nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 2.90nMAssay Description:Binding constant for DRAK1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 3.40nMAssay Description:Binding affinity to DRAK1More data for this Ligand-Target Pair
Affinity DataKd: 3.40nMAssay Description:Binding constant for DRAK1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 4.90nMAssay Description:Binding affinity to DRAK1 (unknown origin)More data for this Ligand-Target Pair
Affinity DataKd: 5nMAssay Description:Inhibition of wild-type human partial length DRAK1 (R32 to E363 residues) expressed in bacterial expression system by Kinomescan methodMore data for this Ligand-Target Pair
Affinity DataKd: 9nMAssay Description:Binding affinity to human N-terminal His-tagged/ TEV cleavage fused DRAK1 (39 to 369 residues) expressed in Escherichia coli by isothermal titration ...More data for this Ligand-Target Pair
Affinity DataKd: 9nMAssay Description:Inhibition of wild-type human partial length DRAK1 (R32 to E363 residues) expressed in bacterial expression system by Kinomescan methodMore data for this Ligand-Target Pair
Affinity DataKd: 10nMAssay Description:Inhibition of wild-type human partial length DRAK1 (R32 to E363 residues) expressed in bacterial expression system by Kinomescan methodMore data for this Ligand-Target Pair
Affinity DataKd: 13nMAssay Description:Binding affinity to DRAK1 (unknown origin)More data for this Ligand-Target Pair
Affinity DataKd: 14nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 14nMAssay Description:Binding constant for DRAK1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 14nMAssay Description:Binding constant for DRAK1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 21nMAssay Description:Average Binding Constant for STK17A; NA=Not Active at 10 uMMore data for this Ligand-Target Pair
Affinity DataKd: 21nMAssay Description:Binding affinity to human N-terminal His-tagged/ TEV cleavage fused DRAK1 (39 to 369 residues) expressed in Escherichia coli by isothermal titration ...More data for this Ligand-Target Pair
3D Structure (crystal)Affinity DataKd: 23nMAssay Description:Average Binding Constant for STK17A; NA=Not Active at 10 uMMore data for this Ligand-Target Pair
Affinity DataKd: 24nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 24nMAssay Description:Binding constant for DRAK1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 24nMAssay Description:Binding constant for DRAK1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 32nMAssay Description:Binding constant for DRAK1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 57nMAssay Description:Average Binding Constant for STK17A; NA=Not Active at 10 uMMore data for this Ligand-Target Pair
Affinity DataKd: 96nMAssay Description:Binding affinity to human DRAK1More data for this Ligand-Target Pair
Affinity DataKd: 99nMAssay Description:Binding affinity to DRAK1 (unknown origin)More data for this Ligand-Target Pair
Affinity DataKd: 110nMAssay Description:Binding constant for DRAK1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 190nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 190nMAssay Description:Binding constant for DRAK1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 190nMAssay Description:Binding constant for DRAK1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 200nMAssay Description:Binding constant for DRAK1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 200nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 230nMAssay Description:Binding affinity to STK17A (unknown origin) by KINOMEscan scanMAX assayMore data for this Ligand-Target Pair
Affinity DataKd: 250nMAssay Description:Binding affinity to STK17A (unknown origin) by KINOMEscan scanMAX assayMore data for this Ligand-Target Pair
Affinity DataKd: 258nMAssay Description:Binding affinity to recombinant full length N-terminal His-FLAG-GST-tagged STK17A (unknown origin) expressed in baculovirus infected Sf9 insect cells...More data for this Ligand-Target Pair
Affinity DataKd: 270nMAssay Description:Binding affinity to STK17A (unknown origin) by KINOMEscan scanMAX assayMore data for this Ligand-Target Pair
Affinity DataKd: 270nMAssay Description:Binding constant for DRAK1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 340nMAssay Description:Binding constant for DRAK1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 367nMAssay Description:Binding affinity to recombinant full length N-terminal His-FLAG-GST-tagged STK17A (unknown origin) expressed in baculovirus infected Sf9 insect cells...More data for this Ligand-Target Pair
Affinity DataKd: 440nMAssay Description:Binding affinity to human STK17A assessed as displacement of immobilized ligand by KINOMEscan scanMAX assay relative to controlMore data for this Ligand-Target Pair
Affinity DataKd: 440nMAssay Description:Binding constant for DRAK1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 440nMAssay Description:Binding affinity to DRAK1 (unknown origin)More data for this Ligand-Target Pair
Affinity DataKd: 440nMAssay Description:Binding constant for DRAK1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 440nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
Affinity DataKd: 610nMAssay Description:Binding constant for DRAK1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 760nMAssay Description:Binding constant for DRAK1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 830nMAssay Description:Binding constant for DRAK1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 830nMAssay Description:Binding constant for DRAK1 kinase domainMore data for this Ligand-Target Pair
Affinity DataKd: 830nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
